Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP478650.RAelmkLX2r6Eg3_Ar7k_DrWK9ZcSWImZAQXarGJTEyZyY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP478650.RAelmkLX2r6Eg3_Ar7k_DrWK9ZcSWImZAQXarGJTEyZyY130_assertion type Assertion NP478650.RAelmkLX2r6Eg3_Ar7k_DrWK9ZcSWImZAQXarGJTEyZyY130_head.
- NP478650.RAelmkLX2r6Eg3_Ar7k_DrWK9ZcSWImZAQXarGJTEyZyY130_assertion description "[However, the substitution of the wild-type GGT (glycine) at codon 12 with a GTT (valine) or a CGT (arginine) showed a strong trend (P = 0.07) toward a poorer prognosis compared with wild-type or other amino acid substitutions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP478650.RAelmkLX2r6Eg3_Ar7k_DrWK9ZcSWImZAQXarGJTEyZyY130_provenance.
- NP478650.RAelmkLX2r6Eg3_Ar7k_DrWK9ZcSWImZAQXarGJTEyZyY130_assertion evidence source_evidence_literature NP478650.RAelmkLX2r6Eg3_Ar7k_DrWK9ZcSWImZAQXarGJTEyZyY130_provenance.
- NP478650.RAelmkLX2r6Eg3_Ar7k_DrWK9ZcSWImZAQXarGJTEyZyY130_assertion SIO_000772 9816185 NP478650.RAelmkLX2r6Eg3_Ar7k_DrWK9ZcSWImZAQXarGJTEyZyY130_provenance.
- NP478650.RAelmkLX2r6Eg3_Ar7k_DrWK9ZcSWImZAQXarGJTEyZyY130_assertion wasDerivedFrom befree-20140225 NP478650.RAelmkLX2r6Eg3_Ar7k_DrWK9ZcSWImZAQXarGJTEyZyY130_provenance.
- NP478650.RAelmkLX2r6Eg3_Ar7k_DrWK9ZcSWImZAQXarGJTEyZyY130_assertion wasGeneratedBy ECO_0000203 NP478650.RAelmkLX2r6Eg3_Ar7k_DrWK9ZcSWImZAQXarGJTEyZyY130_provenance.